Corient Capital Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$671K Buy
8,587
+1
+0% +$91 0.05% 279
2022
Q2
$671K Sell
8,586
-742
-8% -$61.3K 0.05% 292
2022
Q1
$795K Buy
9,328
+1,065
+13% +$102K 0.05% 288
2021
Q4
$991K Sell
8,263
-1,321
-14% -$164K 0.07% 229
2021
Q3
$1.19M Sell
9,584
-221
-2% -$28.4K 0.09% 203
2021
Q2
$1.18M Buy
9,805
+234
+2% +$26.7K 0.09% 200
2021
Q1
$1.01M Buy
9,571
+715
+8% +$72.5K 0.09% 197
2020
Q4
$901K Buy
8,856
+222
+3% +$20.9K 0.09% 190
2020
Q3
$726K Sell
8,634
-1,022
-11% -$79.6K 0.08% 203
2020
Q2
$627K Buy
9,656
+351
+4% +$23.2K 0.08% 224
2020
Q1
$606K Buy
+9,305
New +$733K 0.1% 185

Other funds holding XYL

Corient Capital Partners's XYL Position: Q3 2022 in Review

Corient Capital Partners increased its Xylem (XYL) stake by 0.01% in Q3 2022, buying an estimated $91 and bringing the position to 8,587 shares worth $671K. The position accounts for 0.05% of the portfolio, ranked #279.

Corient Capital Partners first reported a position in XYL in Q1 2020 and has held it in 11 quarters since. The position peaked at $1.19M in Q3 2021. 740 funds tracked by Wall St. Rank hold XYL as of Q3 2022.

  • Corient Capital Partners held 8,587 shares of Xylem worth $671K as of Q3 2022.
  • Corient Capital Partners bought 1 Xylem share in Q3 2022, an estimated $91.
  • Xylem made up 0.05% of Corient Capital Partners's portfolio in Q3 2022, its #279 holding.
  • Corient Capital Partners first reported a position in Xylem in Q1 2020 and has held it in 11 quarters since.
  • Corient Capital Partners's Xylem position peaked at $1.19M in Q3 2021.
  • 740 funds tracked by Wall St. Rank held Xylem as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.